IRADIMED CORP (IRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 30M 60M 90M FY13: 11.3M FY14: 15.7M FY15: 31.6M FY16: 32.5M FY17: 23.1M FY18: 30.4M FY19: 38.5M FY20: 31.7M FY21: 41.8M FY22: 53.3M FY23: 65.6M FY24: 73.2M FY25: 83.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 25M 50M 75M FY13: 8.5M FY14: 12.2M FY15: 25.8M FY16: 26.3M FY17: 17.5M FY18: 23.2M FY19: 29.7M FY20: 23.6M FY21: 32M FY22: 41.3M FY23: 50.2M FY24: 56.4M FY25: 64.3M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-9M 0 9M 18M 27M FY13: 2.8M FY14: 3.1M FY15: 11.5M FY16: 10.9M FY17: 1.3M FY18: 6M FY19: 8.6M FY20: -756.1K FY21: 9.8M FY22: 15.6M FY23: 20M FY24: 22M FY25: 26.1M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 8M 16M 24M FY13: 1.9M FY14: 2.1M FY15: 7.5M FY16: 7.2M FY17: 499.8K FY18: 6.3M FY19: 9.6M FY20: 1.4M FY21: 9.3M FY22: 12.8M FY23: 17.2M FY24: 19.2M FY25: 22.5M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 7M 14M 21M FY13: 2.9M FY14: 3.4M FY15: 5.8M FY16: 6.2M FY17: 5.6M FY18: 7.2M FY19: 8.8M FY20: 8.1M FY21: 9.8M FY22: 12M FY23: 15.4M FY24: 16.9M FY25: 19.5M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 9M 18M 27M FY13: 1.5M FY14: 2.6M FY15: 7.6M FY16: 9.4M FY17: 3.4M FY18: 7.4M FY19: 10.2M FY20: 5.8M FY21: 11.3M FY22: 10M FY23: 13.5M FY24: 25.6M FY25: 24.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 6M 12M 18M FY13: 1.3M FY14: 2M FY15: 7.4M FY16: 8.6M FY17: 2.6M FY18: 7.1M FY19: 9.9M FY20: 5.4M FY21: 10.8M FY22: 9.2M FY23: 6M FY24: 17.6M FY25: 17.2M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 5M 10M 15M FY13: 8.6M FY14: 10.2M FY15: 12.6M FY16: 12M FY17: 11.7M FY18: 12.1M FY19: 12.3M FY20: 12.4M FY21: 12.6M FY22: 12.6M FY23: 12.7M FY24: 12.8M FY25: 12.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.70 1.40 2.10 Q4 '13: 0.22 Q1 '14: 0.21 Q2 '14: 0.25 Q3 '14: 0.24 Q4 '14: 0.21 Q1 '15: 0.27 Q2 '15: 0.31 Q3 '15: 0.44 Q4 '15: 0.60 Q1 '16: 0.67 Q2 '16: 0.71 Q3 '16: 0.69 Q4 '16: 0.61 Q1 '17: 0.40 Q2 '17: 0.24 Q3 '17: 0.13 Q4 '17: 0.04 Q1 '18: 0.13 Q2 '18: 0.21 Q3 '18: 0.39 Q4 '18: 0.52 Q1 '19: 0.60 Q2 '19: 0.66 Q3 '19: 0.66 Q4 '19: 0.78 Q1 '20: 0.77 Q2 '20: 0.43 Q3 '20: 0.32 Q4 '20: 0.11 Q1 '21: 0.08 Q2 '21: 0.37 Q3 '21: 0.48 Q4 '21: 0.74 Q1 '22: 0.83 Q2 '22: 0.97 Q3 '22: 1.04 Q4 '22: 1.03 Q1 '23: 1.10 Q2 '23: 1.17 Q3 '23: 1.30 Q4 '23: 1.36 Q1 '24: 1.41 Q2 '24: 1.46 Q3 '24: 1.46 Q4 '24: 1.50 Q1 '25: 1.55 Q2 '25: 1.62 Q3 '25: 1.65 Q4 '25: 1.75 Q1 '26: 1.83 Q2 '26: 1.79 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.